Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study).

EClinicalMedicine · 2020 · PMC7327891 · PMID 32637899

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In patients with esophageal adenocarcinoma, our meta-analysis showed a trend towards longer OS following NCRT than following NCT, and the HR of NCRT versus surgery alone (HR 0·73, 95% CI 0·62–0·86; high quality) was better than that of NCT versus surgery alone (0·83, 0·72–0·96; moderate quality).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.